. @NatureSMB Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, corresponding Mei Hong @MeiHongLab @ChemistryMIT https://t.co/x4Jcx2C8iP #NMRchat #NMR
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2020 – Dec 2020Where it's discussed
-
X / Twitter28 posts
-
News26 articles
-
Blogs4 articles
-
YouTube2 videos
-
Reddit2 posts
AI synopsis
What people are saying
Discussions emphasize the importance of the structural details revealed in the study, such as the drug-binding sites and the effects of pH on the E protein, with wording like 'sets the stage for designing E inhibitors' and 'potential for antiviral drugs' indicating both curiosity and recognition of significance. The tone varies from scientific technicality to optimistic implications for future therapies, showing active engagement and appreciation for the research's potential impact.
Most discussions acknowledge the significance of the structural insights for drug development, with some explicitly emphasizing the potential for designing inhibitors targeting the E protein.
Participants show high curiosity about the technical methods used, such as solid-state NMR, and the implications for antiviral research, indicating strong interest.
Posts include references to the structural details, drug-binding sites, and experimental techniques, reflecting active engagement in understanding the study's findings.
The discussions highlight the potential influence of this research on future antiviral drug strategies and COVID-19 treatments, suggesting moderate perceived impact.
Abstract in brief
- The SARS-CoV-2 envelope protein (E) forms a pentameric ion channel in lipid bilayers, with a structure revealed by solid-state NMR showing a five-helix bundle featuring unique phenylalanine stacking that causes a dehydrated pore.
- The study identifies drug-binding sites, where Hexamethylene amiloride binds within the polar lumen, and notes that acidic pH influences the protein's conformation, especially at the C-terminal.
- These structural insights suggest that different parts of the channel may interact with viral and host proteins independently, providing a basis for designing antiviral drugs targeting the E protein.]
Top posts
Most liked on X and Bluesky11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2 envelope protein 」 https://t.co/cjySLVRaDp エンベロープ(E)タンパク質が宿主細胞の炎症反応刺激に重要役割を果たしていると
11.11.2020 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers Venkata S. Mandala, Matthew J. McKay, Alexander A. Shcherbakov, Aurelio J. Dregni, Antonios Kolocouris & Mei Hong Nature Structural & Molecular Biology (2020)
New Article: Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers "Here we report a 2.1-Å structure and the drug-binding site of E’s transmembrane domain (ETM), determined using solid-state NMR spectroscopy." https://t.co/KLAzIPSRQJ
DOI https://t.co/b49KvLLnSg
All mentions
Differential Antibody Responses to COVID-19 in Adults and Children
This week we explore the latest COVID-19 news, focusing on distinct antibody responses observed in children and adults. Adult patients demonstrate a wider variety of antibody responses, while children show a more…
Structural Insights into SARS-CoV-2 Envelope Protein for Drug Development
This video explores the structure of the SARS-CoV-2 envelope protein forming a pentameric ion channel with unique phenylalanine stacking, offering potential drug binding sites and insights crucial for antiviral drug…
@marcinwarchol @MZ_GOV_PL https://t.co/hLFgOfsL4K Article Published: 11 November 2020 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers
RT @NanionTech:
DOI https://t.co/b49KvLLnSg
11.11.2020 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers Venkata S. Mandala, Matthew J. McKay, Alexander A. Shcherbakov, Aurelio J. Dregni, Antonios Kolocouris & Mei Hong Nature Structural & Molecular Biology (2020)
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
RT @keyaki1117: 11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2…
11月11日の「Nature Structural & Molecular Biology」に発表されたMIT大学の新型コロナウイルス研究が話題に。 論文は「Structure and drug binding of the SARS-CoV-2 envelope protein 」 https://t.co/cjySLVRaDp エンベロープ(E)タンパク質が宿主細胞の炎症反応刺激に重要役割を果たしていると
Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid... - https://t.co/EMuRJPJPhe #ScholarAlerts
NJs/ Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.https://t.co/gVODFpGKRi
RT @nmr900: . @NatureSMB Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, correspondin…
New Article: Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers "Here we report a 2.1-Å structure and the drug-binding site of E’s transmembrane domain (ETM), determined using solid-state NMR spectroscopy." https://t.co/KLAzIPSRQJ
Structure and drug binding of the SARS-CoV-2 envelope protein E transmembrane domain (ETM) sets the stage for designing E inhibitors as #antiviral drugs. #COVID19 #coronavirus (#Nature, 11 Nov 2020) Source in comments. https://t.co/hsnS1YRHRm
RT @nmr900: . @NatureSMB Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, correspondin…
RT @nmr900: . @NatureSMB Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, correspondin…
. @NatureSMB Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, corresponding Mei Hong @MeiHongLab @ChemistryMIT https://t.co/x4Jcx2C8iP #NMRchat #NMR
@APSFA Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers | Research Square https://t.co/KhM4MfiQ4a
(Nature in review) Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers, Mei Hong, Venkata Mandala, Matthew McKay, Alexander Shcherbakov, Aurelio Dregni, Antonios Kolocouris https://t.co/xYQ8beW0Hs #NMRchat #NMR